Biodegradable alpha-2 adrenergic agonist polymeric implants

Details for Australian Patent Application No. 2009314266 (hide)

Owner Allergan, Inc.

Inventors Spada, Lon T.; Ghebremeskel, Alazar N.; Robinson, Michael R.

Agent Davies Collison Cave

Pub. Number AU-A-2009314266

PCT Pub. Number WO2010/056598

Priority 12/272,548 17.11.08 US

Filing date 6 November 2009

Wipo publication date 20 May 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61F 2/16 (2006.01) Filters - Intraocular lenses

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/056598 Priority application(s): WO2010/056598

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314271-Method and system for forming a dental prosthesis

2009314263-Adjusting payback data based on skill